Dr. Yulian Khagi, MD

Dr. Khagi practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Khagi's NPI, 1710253638, was assigned on March 25, 2012. Dr. Khagi graduated from Saint Louis University School Of Medicine in 2008. Dr. Khagi holds California license A135306.

Dr. Khagi's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Khagi's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Khagi is also affiliated with Providence Mission Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Khagi to 1 more hospital, 1 group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khagi practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Khagi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khagi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Khagi's licenses on file in 2 states: California and New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Khagi treats.

CMS data shows 1,421 Medicare services from Dr. Khagi across 7 procedure codes in 2024, for 333 Medicare patients. Medicare paid $123,018 for them. Every service was in an office.

CMS counts 333 Medicare patients who saw Dr. Khagi in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khagi's median patient age at 65, with 59% women.

In 2024, Dr. Khagi wrote 449 Medicare Part D claims for 64 patients. 74% of them were for generic drugs. CMS names the drug for 280 of them, across 11 drugs with 11 or more claims each, at $492,390 in total drug cost. In 2023, CMS named 179 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Khagi for performance year 2024, reported through an alternative payment model (APM). Dr. Khagi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khagi as offering telehealth.

Dmand AI links 6 papers to Dr. Khagi, published from 2011 to 2020. The most frequent topics are Biomarkers, Tumor. Dr. Khagi's most frequent co-authors are Aaron Michael Goodman, MD, Sandip Pravin Patel, MD and Lyudmila A. Bazhenova, MD.

CMS Open Payments shows 120 general payments to Dr. Khagi from 20 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Sanofi and Genzyme US Companies paid the most, $45,829.

Dmand AI lists 8 awards for Dr. Khagi, most recently Medical Oncology Academy Award in 2021.

Dr. Khagi graduated from Saint Louis University School Of Medicine in 2008. Dr. Khagi is a member of American College of Physicians, American Society of Clinical Oncology, American Society of Hematology, Association of American Physicians and Surgeons and Medical Oncology Association of Southern California (MOASC).

Dr. Khagi is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.